. Author manuscript; available in PMC: 2013 Sep 6.

Published in final edited form as: J Urol. 2012 Jun 15;188(2):514–520. doi: 10.1016/j.juro.2012.04.001

Table 1.

Demographics of erectile dysfunction in the UroEDIC genotyped cohort

CHARACTERISTIC	No Erectile Dysfunction (n=403)	Erectile Dysfunction (n=125)	p-value
Sociodemographic Attained Age(yr)^*	43.5 (6.5)	48.2 (5.9)	0.00098
Diabetes Treatment and Control Intervention No. (%)			0.11
Intensive therapy	207 (51.3)	54 (43.2)
Conventional therapy	196 (48.7)	71 (56.8)
Cohort No.(%)			0.30
Primary	205 (50.9)	57 (45.6)
Secondary	198 (49.1)	68 (54.4)
HemoglobinA1c at DCCT baseline (%)	8.6 (1.5)	9.0 (1.5)	0.016
DCCT/EDIC mean Hemoglobin A1c	8.0 (1.3)	8.6 (1.4)	0.00076
Insulin dose (units/kg/day)^*	0.66 (0.26)	0.63 (0.23)	0.40

Assessed at EDIC year 10. All data are expressed as mean (SD) unless noted otherwise. P-values calculated based on chi-square for differences in proportions and linear regression for continuous measures.